Results 91 to 100 of about 2,994 (188)

Glomerular plasmalemma vesicle‐associated protein‐1 as an endothelial remodelling marker complementing C4d in chronic active antibody‐mediated rejection

open access: yesHistopathology, Volume 89, Issue 2, Page 372-382, August 2026.
Glomerular plasmalemma vesicle‐associated protein‐1 (PV‐1/PLVAP) identifies dynamic endothelial remodelling in chronic active antibody‐mediated rejection (caABMR), complementing glomerular C4d, which reflects a static footprint of complement activation. Combined assessment of PV‐1 and C4d captures complementary dimensions of microvascular pathology and
Yuto Igarashi   +7 more
wiley   +1 more source

Clinicopathological findings, correlations and outcomes in patients with renal disease and living with antiretroviral‐treated human immunodeficiency virus infection

open access: yesInternal Medicine Journal, Volume 56, Issue 8, Page 1402-1411, August 2026.
Abstract Background and Aims Antiretroviral therapy (ART) has modified the incidence of renal complications and the patterns of renal disease in people living with Human Immunodeficiency Virus (PLWH). We reviewed (2011–2021) the progress and outcomes (follow‐up to mid‐2025) of 158 such individuals.
Jacqueline A. Evans   +5 more
wiley   +1 more source

Thrombotic microangiopathies after kidney transplantation in modern era: nosology based on chronology. [PDF]

open access: yesBMC Nephrol, 2023
Von Tokarski F   +11 more
europepmc   +1 more source

Persistent Haematuria Is Associated With Reduced Kidney Survival in Primary Podocytopathies

open access: yesNephrology, Volume 31, Issue 8, August 2026.
ABSTRACT Aim Haematuria is frequently present in podocytopathies, but its significance and prognostic value are not well described. This study aimed to determine the prevalence and association between persistent haematuria and kidney survival in patients with membranous nephropathy (MN), minimal change disease (MCD) and focal segmental ...
Gabriel Ștefan   +3 more
wiley   +1 more source

Beyond the Transplant: Chronic Kidney Disease in Pediatric Hematopoietic Stem Cell Transplant Survivors‐A 20‐Year Single‐Center Cohort Study

open access: yesPediatric Transplantation, Volume 30, Issue 8, August 2026.
Pediatric HSCT survivors face a substantial and rising risk of chronic kidney disease‐ 16.5% by five years post‐transplant in this 20‐year, 261‐patient cohort, particularly among those transplanted at older ages. These findings support systematic long‐term renal surveillance as part of post‐transplant survivorship care.
Alcotzer Inbar   +7 more
wiley   +1 more source

Epidemiology, Outcomes, and Complement Gene Variants in Secondary Thrombotic Microangiopathies. [PDF]

open access: yesClin J Am Soc Nephrol, 2023
Werion A   +18 more
europepmc   +1 more source

Machine Perfusion and Mitigating Risk Factors for Delayed Graft Function in Pediatric Kidney Transplant Recipients

open access: yesPediatric Transplantation, Volume 30, Issue 8, August 2026.
In a single‐center retrospective study of 89 pediatric kidney transplant recipients, warm ischemia time > 43.5 min and deceased donor kidneys were associated with delayed graft function (DGF), while machine perfusion appeared protective (0% vs. 26% DGF). These findings suggest machine perfusion may mitigate DGF risk in pediatric kidney transplantation.
Kyle A. Merrill   +7 more
wiley   +1 more source

Acquired thrombotic thrombocytopenic purpura and HIV infection: a case report and review of the literature

open access: yesAnnals of Hematology
Human immunodeficiency virus (HIV) is a rare cause of thrombotic microangiopathies (TMA), that can present either with normal ADAMTS13 activity (referred as HIV-related TMA) or suppressed ADAMTS13 activity (referred as HIV-related acquired thrombotic ...
Silvio Rao   +6 more
doaj   +1 more source

Malignant hypertension as a rare cause of thrombotic microangiopathy associated with end-stage renal disease

open access: yesAsian Journal of Internal Medicine
Malignant hypertension (MH) can precipitate and worsen renal thrombotic microangiopathy. Also, renal thrombotic microangiopathies (TMA) can cause malignant hypertension. Case reports regarding this clinical presentation are limited.
J. C. Charles, S. Yathukulan
doaj   +1 more source

Home - About - Disclaimer - Privacy